These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 18269586)

  • 1. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas.
    Rizvi SM; Goodwill J; Lim E; Yap YK; Wells AU; Hansell DM; Davis P; Selim AG; Goldstraw P; Nicholson AG
    Histopathology; 2009 Sep; 55(3):332-7. PubMed ID: 19723148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 protein expression in neuroendocrine tumors of the lung.
    Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
    Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels.
    Salon C; Brambilla E; Brambilla C; Lantuejoul S; Gazzeri S; Eymin B
    J Pathol; 2007 Nov; 213(3):303-10. PubMed ID: 17823919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
    Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
    Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
    Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
    Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumour type.
    Davidson LA; Black M; Carey FA; Logue F; McNicol AM
    J Pathol; 1996 Apr; 178(4):398-401. PubMed ID: 8691317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
    Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
    J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications.
    Roncalli M; Doglioni C; Springall DR; Papotti M; Pagani A; Polak JM; Ibrahim NB; Coggi G; Viale G
    Diagn Mol Pathol; 1992 Jun; 1(2):129-35. PubMed ID: 1364172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine structures in normal and diseased human lung.
    Mosca L; Ceresoli A; Anzanello E; Mauri F; Mariscotti C; Timossi R; Barbareschi M; Mezzetti M
    Appl Pathol; 1986; 4(3):147-61. PubMed ID: 3036186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent differentiation in neuroendocrine lung tumors.
    Brambilla E; Lantuejoul S; Sturm N
    Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
    Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
    Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.